Research on the current situation and coping strategies for cervical cancer in China
DOI:
https://doi.org/10.54097/hset.v2i.551Keywords:
Cervical cancer, The vaccine, Existing problems, Countermeasures and suggestionsAbstract
Cervical cancer caused by human papilloma virus has become one of the most common cancers threatening the life and health of Chinese women.The incidence and mortality of cervical cancer in China has always been high, and cervical cancer has become the sixth most common disease among Chinese women.In this paper, the status quo and existing problems of cervical cancer in China were analyzed, and combined with the actual work of the current immunization program, the vaccination rate of human papilloma virus vaccine was strengthened to help achieve the goal of eliminating cervical cancer.
Downloads
References
Yao Peixin, Ning Chunxue, Xia Fang, He Yufang. Research on problems and countermeasures of HPV vaccination service[J]. Journal of Changchun University of Traditional Chinese Medicine.2022(03):346-349
ZHAO F, QIAO Y. Cervical cancer prevention in China: a key to cancer control[J]. Lancet, 2019, 393(10175): 969-970.
Han JJ, Beltran TH, Song J W, et al. Prevalence of Genital Human Papilloma virus Infection and Human Papilloma virus Vaccination Rates Among US Adult Men[J]. JAMA Oncology, 2017,3(6):810
Lai Jiang-Yi, Wu Xia-qiu. Human papilloma virus and its vaccine awareness and vaccination willingness among female college students in Hangzhou city [J]. China Vaccine & Immunization, 2019, 25 (03) :303-307.
GARBUGLIA AR, LAPA D, SIAS C, et al. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papilloma virus Disease[J]. Front Immunol, 2020, 11: 188.
Zhang Qiqi. Investigation on awareness and vaccination intention of cervical cancer among female college students in Xinjiang under health intervention [D]. Urumqi: Xinjiang Medical University, 2021.
GONG L, JI HH, TANG XW, et al. Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of vaccine adverse event reporting system[J]. Sci Rep, 2020, 10(1): 1-8.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
